• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高初级保健中认知障碍的识别率和随访率:一项质量改进试点研究。

Increasing Identification and Follow-Up of Cognitive Impairment in Primary Care: A Quality Improvement Pilot Study.

机构信息

Patricia A. Chin School of Nursing, California State University, Los Angeles, CA, USA.

出版信息

J Prim Care Community Health. 2024 Jan-Dec;15:21501319241277397. doi: 10.1177/21501319241277397.

DOI:10.1177/21501319241277397
PMID:39238271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11378207/
Abstract

INTRODUCTION

Beyond our population growing older and living longer, there is an increased risk of developing a cognitive disorder. Standardized screening during a routine visit in primary care may be ideal for early detection of mild cognitive impairment (MCI) and follow-up for cognitive changes.

AIM

This quality improvement (QI) project aimed to determine the impact of implementing the Mini-Cog© quick screening for early dementia detection to identify and follow up on the cognitive impairment of older adults in a primary care clinic setting.

METHODS

Implementation started in February 2024 in a primary care clinic in Southern California. Data was collected for this project over a total of 16 weeks. This QI project implemented a routine cognitive screening using the Mini-Cog©. Cognitive impairment was identified, and if indicated by the Mini-Cog© scores, follow-up for a cognitive assessment and care plan services were initiated. Data were obtained from the project site's electronic medical record on a total sample size of 471 participants (n = 382 in the pre-implementation group and n = 89 in the post-implementation group).

RESULTS

Pearson's chi-square test indicated a statistically significant improvement in the identification rate of cognitive impairment, increasing from 11.8% (n = 45 out of 382) at pre-implementation to 34.8% (n = 31 out of 89) at post-implementation, and specifically, mild cognitive impairment increased from zero identified in pre-implementation to 12.4% (n = 11 out of 89) post-implementation. Lastly, follow-up rates improved from 91.1% (n = 41 out of 45) to 100% (n = 31 out of 31) in post-implementation, and clinical significance was evident based on the phi-coefficient ( = 0.196), indicating a small effect size and a 100% follow-up rate.

CONCLUSIONS

The findings of this project suggest older adults should receive cognitive screenings to help identify early cognitive impairment and increase follow-up for further evaluation, treatment, and advanced care planning.

摘要

简介

除了人口老龄化和寿命延长之外,人们患上认知障碍的风险也在增加。在初级保健常规就诊期间进行标准化筛查可能是早期发现轻度认知障碍(MCI)并对认知变化进行随访的理想方法。

目的

本质量改进(QI)项目旨在确定实施 Mini-Cog©快速筛查以早期发现痴呆症来识别和随访初级保健诊所中老年患者认知障碍的影响。

方法

该项目于 2024 年 2 月在加利福尼亚州南部的一家初级保健诊所开始实施。本项目共收集了 16 周的数据。该 QI 项目使用 Mini-Cog©进行常规认知筛查。如果 Mini-Cog©评分提示认知障碍,则进行认知评估和护理计划服务的随访。数据来自项目现场的电子病历,总样本量为 471 名参与者(n=382 名在实施前组,n=89 名在实施后组)。

结果

Pearson's 卡方检验表明认知障碍的识别率有统计学意义的提高,从实施前的 11.8%(n=382 中的 45 例)增加到实施后的 34.8%(n=89 中的 31 例),特别是轻度认知障碍从实施前的零例增加到实施后的 12.4%(n=89 中的 11 例)。最后,实施后的随访率从 91.1%(n=45 中的 41 例)提高到 100%(n=31 中的 31 例),并且基于 phi 系数( = 0.196),临床意义明显,表明小效应量和 100%的随访率。

结论

本项目的研究结果表明,老年人应接受认知筛查,以帮助识别早期认知障碍,并增加随访,以进行进一步评估、治疗和高级护理计划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b965/11378207/a0d5d1b6a175/10.1177_21501319241277397-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b965/11378207/f0488d498924/10.1177_21501319241277397-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b965/11378207/1247fbeba7fc/10.1177_21501319241277397-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b965/11378207/8428eb9889b3/10.1177_21501319241277397-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b965/11378207/a0d5d1b6a175/10.1177_21501319241277397-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b965/11378207/f0488d498924/10.1177_21501319241277397-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b965/11378207/1247fbeba7fc/10.1177_21501319241277397-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b965/11378207/8428eb9889b3/10.1177_21501319241277397-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b965/11378207/a0d5d1b6a175/10.1177_21501319241277397-fig4.jpg

相似文献

1
Increasing Identification and Follow-Up of Cognitive Impairment in Primary Care: A Quality Improvement Pilot Study.提高初级保健中认知障碍的识别率和随访率:一项质量改进试点研究。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241277397. doi: 10.1177/21501319241277397.
2
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
3
Reminiscence therapy for dementia.痴呆症的回忆疗法
Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3.
4
Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting.在初级保健机构中用于诊断阿尔茨海默病性痴呆及其他痴呆的简易认知评估工具。
Cochrane Database Syst Rev. 2018 Feb 22;2(2):CD011415. doi: 10.1002/14651858.CD011415.pub2.
5
Algorithm-based pain management for people with dementia in nursing homes.基于算法的养老院痴呆患者疼痛管理。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD013339. doi: 10.1002/14651858.CD013339.pub2.
6
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
7
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.抗血栓治疗预防神经影像学检查发现的小血管疾病但无痴呆的患者认知能力下降。
Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2.
10
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.

本文引用的文献

1
Current Anti-Amyloid-β Therapy for Alzheimer's Disease Treatment: From Clinical Research to Nanomedicine.当前用于治疗阿尔茨海默病的抗淀粉样β蛋白疗法:从临床研究到纳米医学
Int J Nanomedicine. 2023 Dec 20;18:7825-7845. doi: 10.2147/IJN.S444115. eCollection 2023.
2
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics.抗淀粉样蛋白单克隆抗体是具有变革性的治疗方法,重新定义了阿尔茨海默病的治疗方法。
Drugs. 2023 May;83(7):569-576. doi: 10.1007/s40265-023-01858-9. Epub 2023 Apr 15.
3
Checking the validity and reliability of the Japanese version of the Mini-Cog using a smartphone application.
使用智能手机应用程序检查 Mini-Cog 日语版的有效性和可靠性。
BMC Res Notes. 2022 Jun 25;15(1):222. doi: 10.1186/s13104-022-06101-4.
4
Assessment of the diagnostic accuracy and discriminative validity of the Clock Drawing and Mini-Cog tests in detecting cognitive impairment.评估画钟测验和迷你认知测验在检测认知障碍方面的诊断准确性和鉴别有效性。
Neurologia (Engl Ed). 2022 Jan-Feb;37(1):13-20. doi: 10.1016/j.nrleng.2018.12.022. Epub 2021 Sep 17.
5
Optimizing the diagnosis and management of dementia within primary care: a systematic review of systematic reviews.优化初级保健中痴呆症的诊断与管理:系统评价的系统综述
BMC Fam Pract. 2021 Aug 11;22(1):166. doi: 10.1186/s12875-021-01461-5.
6
Dementia assessment and management in primary care settings: a survey of current provider practices in the United States.基层医疗环境中的痴呆症评估与管理:美国当前医疗服务提供者实践的调查
BMC Health Serv Res. 2019 Nov 29;19(1):919. doi: 10.1186/s12913-019-4603-2.
7
Comparison of the value of Mini-Cog and MMSE screening in the rapid identification of Chinese outpatients with mild cognitive impairment.Mini-Cog与MMSE筛查在快速识别中国轻度认知障碍门诊患者中的价值比较
Medicine (Baltimore). 2018 Jun;97(22):e10966. doi: 10.1097/MD.0000000000010966.
8
Psychometric Properties of the Persian Adaptation of Mini-Cog Test in Iranian Older Adults.伊朗老年人中简易认知功能测试波斯语版的心理测量学特性
Int J Aging Hum Dev. 2018 Apr;86(3):266-280. doi: 10.1177/0091415017724547. Epub 2017 Aug 31.
9
Validation and cultural adaptation of the Arabic versions of the Mini-Mental Status Examination - 2 and Mini-Cog test.简易精神状态检查表-2(Mini-Mental Status Examination - 2)和简易认知测试(Mini-Cog test)阿拉伯语版本的验证与文化适应性研究
Neuropsychiatr Dis Treat. 2017 Mar 14;13:793-801. doi: 10.2147/NDT.S126825. eCollection 2017.
10
The Mini-Cog as a screen for dementia: validation in a population-based sample.作为痴呆筛查工具的简易认知评估量表:基于人群样本的验证
J Am Geriatr Soc. 2003 Oct;51(10):1451-4. doi: 10.1046/j.1532-5415.2003.51465.x.